OXT and breast cancer: Chen et al. developed a 2 CpG marker comprising cg21472506 (of OTX1) and cg11437784 (of SOX1-OT) panel for BC detection and surveillance that discriminates BC patients with SN/SP of 90%/83.1%, also showing enhanced sensitivity (64.5%) for LG NMIBC [112].